Tag: Clinical trial News

Indian healthcare attributes the success of transplants to improved organ preservation and anti-rejection medications.

The success of organ transplants in India is credited to improved organ preservation techniques, cutting-edge surgery, and anti-rejection medications. When a patient has serious organ failure, organ transplantation is a crucial therapy option. Both patient survival and quality of life…

In order to better manage the rare disease Myasthenia gravis, UCB and Huma have partnered to develop digital health solutions.

With the support of their physician, patients with the uncommon disease Myasthenia gravis (MG) can better understand and manage their condition thanks to a partnership between UCB and Huma Therapeutics (Huma), a leading global digital health company and global biopharmaceutical…

To evaluate the PEF rate of lung function in asthma patients, Tenovi develops a cellular remote Peak Flow Metre that has been approved by the US FDA.

Tenovi offers Tenovi, a leader in US FDA-approved remote patient monitoring (RPM) solutions, recently announced the release of its cellular-enabled remote Peak Expiratory Flow Metre (PFM). The device enables asthma sufferers to quickly communicate peak expiratory flow rate (PEF) and…

Sulbactam-durlobactam from Innoviva should be approved by the US FDA to treat ventilator-associated bacterial pneumonia and hospital-acquired bacterial pneumonia.

The US Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted 12-0 in favour of approval of sulbactam-durlobactam for the treatment of adults with ventilator-associated bacterial pneumonia and hospital-acquired bacterial pneumonia caused by susceptible strains, according to…

For Medicare users, Abbott’s FreeStyle Libre continuous glucose monitoring systems receive significantly greater coverage.

Abbott’s FreeStyle Libre portfolio, the most widely used and reasonably priced continuous glucose monitoring system (CGM) in the United States, will now make more Medicare beneficiaries than ever before eligible for reimbursement when using it. According to Jared Watkin, executive…

In persons with certain forms of adjuvant liver cancer, Roche reports that the Tecentriq + Avastin phase III IMbrave050 research lowers the likelihood of the cancer coming back.

Avastin (bevacizumab) plus Tecentriq (atezolizumab) showed a statistically significant improvement in recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following liver resection or ablation with the intention of curing the disease, according to…

Back to top

Registration Form


This will close in 0 seconds

This will close in 0 seconds

WhatsApp Join Telegram